Haemophilus Influenzae Type b Diseases Completed Phase 3 Trials for Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584)

Also known as: Haemophilus Influenzae Type b Disease

IndicationStatusPhase
DBCOND0035438 (Haemophilus Influenzae Type b Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01309646Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib VaccinePrevention
NCT00508261Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each VaccinePrevention
NCT00586612Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm InfantsPrevention
NCT00412854Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.Prevention
NCT00696423Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in ChildrenPrevention
NCT00964028Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)Prevention
NCT01086423Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ VaccinePrevention
NCT00322335Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenCPrevention
NCT00327184Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC VaccinePrevention
NCT00879827Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsPrevention